Open Access
Global Trends and Interactions With the HIV Epidemic
Elizabeth L. Corbett,Catherine J. Watt,Neff Walker,Dermot Maher,Brian G. Williams,Mario C. Raviglione,Christopher Dye +6 more
- 01 Jan 2017
1.8K
TL;DR: The authors in this paper reviewed data from notifications of TB cases, cohort treatment outcomes, surveys of Mycobacterium tuberculosis infection, and HIV prevalence in patients with TB and other subgroups.
read more
Abstract: BACKGROUND
The increasing global burden of tuberculosis (TB) is linked to human immunodeficiency virus (HIV) infection.
METHODS
We reviewed data from notifications of TB cases, cohort treatment outcomes, surveys of Mycobacterium tuberculosis infection, and HIV prevalence in patients with TB and other subgroups. Information was collated from published literature and databases held by the World Health Organization (WHO), the Joint United Nations Programme on HIV/Acquired Immunodeficiency Syndrome (UNAIDS), the US Census Bureau, and the US Centers for Disease Control and Prevention.
RESULTS
There were an estimated 8.3 million (5th-95th centiles, 7.3-9.2 million) new TB cases in 2000 (137/100,000 population; range, 121/100,000-151/100,000). Tuberculosis incidence rates were highest in the WHO African Region (290/100,000 per year; range, 265/100,000-331/100,000), as was the annual rate of increase in the number of cases (6%). Nine percent (7%-12%) of all new TB cases in adults (aged 15-49 years) were attributable to HIV infection, but the proportion was much greater in the WHO African Region (31%) and some industrialized countries, notably the United States (26%). There were an estimated 1.8 million (5th-95th centiles, 1.6-2.2 million) deaths from TB, of which 12% (226 000) were attributable to HIV. Tuberculosis was the cause of 11% of all adult AIDS deaths. The prevalence of M tuberculosis-HIV coinfection in adults was 0.36% (11 million people). Coinfection prevalence rates equaled or exceeded 5% in 8 African countries. In South Africa alone there were 2 million coinfected adults.
CONCLUSIONS
The HIV pandemic presents a massive challenge to global TB control. The prevention of HIV and TB, the extension of WHO DOTS programs, and a focused effort to control HIV-related TB in areas of high HIV prevalence are matters of great urgency.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
AIDS-defining causes of death from autopsy findings for HIV-positive individuals in sub-Saharan Africa in the pre- and post-ART era: A systematic review and meta-analyses
Nazia Peer,Isaac I. Bogoch,Isaac I. Bogoch,Quique Bassat,Leslie Newcombe,Leah K. Watson,Nico J. D. Nagelkerke,Prabhat Jha,Prabhat Jha +8 more
- 17 Jul 2019
TL;DR: Even though ART has reduced the contribution of OIs to causes of death for people infected with HIV in SSA, targeted and strategic efforts are needed in order to strengthen existing prevention, diagnosis, and treatment of TB.
5
Tuberculosis en la comarca del Bajo Deba (Guipúzcoa) en el período 1995-2006
TL;DR: The Bajo Deba Area presented a high incidence of tuberculosis in the 1995 to 2006 period, and epidemiological trends showed a progressive decrease in the number of tuberculosis patients, with a shift from younger to older persons as the most highly affected age group.
5
•Dissertation
Clinical and laboratory features of HIV/AIDS in the Kingdom of Saudi Arabia
Wail Bajhmoum
- 09 Jun 2015
TL;DR: HIV/AIDS and related coinfections are medical problems in Saudi Arabia with many social challenges and more detailed studies are needed on clinical patterns in outpatient and inpatient settings and on locally appropriate prevention programmes in high risk groups.
5
Pre-HAART CD4+ T-lymphocytes as biomarkers of post-HAART immune recovery in HIV-infected children with or without TB co-infection.
Vivek Gopalakrishnan,Eliezer Bose,Usha Nair,Yuwei Cheng,Musie Ghebremichael,Musie Ghebremichael +5 more
TL;DR: Pre-HAART CD4+ T-lymphocyte count and percentage are stronger predictors of immune recovery in TB-negative pediatric patients, suggesting that TB co-infection complicates the treatment of HIV in this cohort.
Identification of HLA-A24-Binding Peptides of Mycobacterium tuberculosis Derived Proteins with Beta 2m Linked HLA-A24 Single Cha
TL;DR: From a group of peptides predicted as binders by a computer algorithm, five peptides were shown to bind to HLA-A24 protein on the cell surface and the cell line and HLA binders present here would be useful for further identification of CD8 restricted Mtb epitopes.
5
References
Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country
TL;DR: The global burden of tuberculosis remains enormous, mainly because of poor control in Southeast Asia, sub-Saharan Africa, and eastern Europe, and because of high rates of M tuberculosis and HIV coinfection in some African countries.
A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
Peter A. Selwyn,Diana Hartel,Victor A. Lewis,Ellie E. Schoenbaum,Sten H. Vermund,Robert S. Klein,Angela T. Walker,Gerald Friedland +7 more
TL;DR: The data suggest that in HIV-infected persons tuberculosis most often results from the reactivation of latent tuberculous infection; these results lend support to recommendations for the aggressive use of chemoprophylaxis against tuberculosis in patients with HIV infection and a positive PPD test.
1.6K
An Outbreak of Tuberculosis With Accelerated Progression Among Persons Infected With the Human Immunodeficiency Virus. An Analysis Using Restriction-Fragment-Length Polymorphisms
Charles L. Daley,Peter M. Small,Gisela F. Schecter,Gary K. Schoolnik,Ruth Mcadam,William R. Jacobs,Philip C. Hopewell +6 more
TL;DR: There should be heightened surveillance for tuberculosis in facilities where HIV-infected persons live, and investigation of contacts must be undertaken promptly and be focused more broadly than is usual.
1K
Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and Rifampin
TL;DR: For patients with pulmonary tuberculosis that is resistant to rifampin and isoniazid, even the best available treatment is often unsuccessful, and only about half of such patients eventually have negative sputum cultures despite carefully selected regimens administered for extended periods.
755
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
Marcos A. Espinal,Adalbert Laszlo,Lone Simonsen,Fadila Boulahbal,S. J. Kim,Ana Reniero,Sven Hoffner,Hans L. Rieder,Nancy J. Binkin,Christopher Dye,Rosamund Williams,Mario C. Raviglione +11 more
TL;DR: The survey conducted by the World Health Organization and the International Union against Tuberculosis and Lung Disease to assess trends in resistance to antituberculosis drugs in countries on six continents found that for patients with newly diagnosed tuberculosis, the frequency of resistance to at least one antituber tuberculosis drug ranged from 1.7 percent in Uruguay to 36.9 percent in Estonia.
735